Streetbeat News

Products Services

ELTX

Elicio Therapeutics' stock price is on the rise following the announcement of positive preclinical data showing that its TCR-T cell therapy, when combined with lymph node-targeted amphiphile-immunotherapy, has improved anti-tumor functions and successfully eradicated solid tumors.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 8:32 pm

ABT

Abbott Laboratories (NYSE:ABT) has received FDA approval for its Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation device designed to treat movement disorders. The device requires minimal recharges and is compatible with Abbott's NeuroSphere Virtual Clinic, allowing remote communication and treatment adjustments with healthcare providers. The Liberta RC DBS system is significantly smaller than other devices and offers a convenient wireless charging system with customizable settings.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 8:20 pm

AXSM

RBC Capital initiated coverage on Axsome Therapeutics Inc (NASDAQ:AXSM) with an Outperform rating and a price target of $126, citing underappreciated near-term revenue growth and pipeline potential. Auvelity, Axsome's drug for major depressive disorder, is expected to surpass consensus sales estimates in 2024 with $296 million. The company's preliminary Q4 2023 product revenue is approximately $71 million, with full-year revenue at $204 million. Auvelity and Sunosi are the main contributors to these figures. AXSM shares are currently down 1.17% at $90.71.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 8:08 pm

BZFD

BuzzFeed Inc (NASDAQ:BZFD) and Vice Media are facing financial difficulties, leading to downsizing and asset sales. BuzzFeed's stock has dropped over 97% since its 2021 IPO, and it is now looking to sell its food-focused sites Tasty and First We Feast. Vice Media, overseen by Fortress Investment Group after bankruptcy, is trying to sell Refinery29 after a failed attempt to sell the entire company. Both companies are struggling with a volatile advertising market and reduced traffic, reflecting broader industry challenges for digital media.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 8:06 pm

HLN

Haleon PLC (NYSE:HLN) has announced a recall of certain lots of its Robitussin cough syrups due to microbial contamination, which could be life-threatening for immunocompromised individuals. The recall affects nearly 10 lots of Robitussin Honey CF Max Day Adult and Honey CF Max Nighttime Adult. No adverse reactions have been reported. Despite the recall, Haleon's stock was trading higher, although it has underperformed the market over the last year.

Portfolio Pulse from Aaron Bry

January 25, 2024 | 8:04 pm

MUSQ

The 66th GRAMMY Awards will feature performances by Travis Scott, Luke Combs, Burna Boy, Billie Eilish, Dua Lipa, and Olivia Rodrigo, airing on CBS on February 4th. Taylor Swift and Billie Eilish could make history with their nominations. Three new GRAMMY categories have been introduced. The MUSQ Global Music Industry ETF (NYSE:MUSQ) offers investors exposure to the music industry and is currently showing a potential bull flag pattern, indicating a possible 4.5% increase in value.

Portfolio Pulse from Johnny Rice

January 25, 2024 | 7:57 pm

TSLA

Jim Cramer removed Tesla Inc (TSLA) from the 'Magnificent Seven' due to its recent underperformance and disappointing quarterly results. Tesla's stock has been in a downtrend since late 2021, losing a quarter of its value this year. Cramer sees a potential return for Tesla to the group with its new mass-market EV 'Redwood', expected to start production in 2025. Despite a 'train wreck' conference call, Cramer isn't giving up on Tesla long-term and suggests Eli Lilly could join the mega-cap index.

Portfolio Pulse from Adam Eckert

January 25, 2024 | 7:54 pm

AAPL

SPOT

UMGNF

Spotify Technology SA (SPOT) is optimistic about the European Union's Digital Markets Act (DMA), which will allow it to share details about deals and payment options within the EU. The DMA, effective March 7, challenges Apple Inc's (AAPL) control in various digital markets. Spotify plans to introduce 'superfan clubs' and other features to enhance user and creator experiences. Universal Music Group NV (UMGNF) is also interested in creating 'superfan experiences.' Apple may respond to the DMA with new fees and restrictions, which could lead to further disputes with Spotify.

Portfolio Pulse from Franca Quarneti

January 25, 2024 | 7:44 pm

AAPL

MTCH

RBLX

SPOT

Apple Inc (AAPL) is overhauling its App Store in Europe to comply with the EU's Digital Markets Act, set to take effect on March 7. The changes will allow alternative app stores and payment methods, and introduce a new menu for browsers. This has caused shares of companies like Roblox (RBLX), Spotify (SPOT), and Match Group (MTCH) to rise, while Apple's shares fell by about 1%.

Portfolio Pulse from Adam Eckert

January 25, 2024 | 7:35 pm

REGN

Regeneron Pharmaceuticals has announced that the FDA has approved Dupixent for use in children aged 1 year and older with Eosinophilic Esophagitis, a chronic immune system disease. This approval could potentially expand the patient base for Dupixent, which is already used to treat several other allergic inflammatory diseases.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 7:30 pm